Carbometrics

About:

Carbometrics is a specialist chemistry company to help people with diabetes to live more normal and longer lives.

Website: https://www.carbometrics.com

Twitter/X: carbometrics

Top Investors: SCVC, Parkwalk Advisors, Ada Ventures, Selvedge Venture, Télécom ParisTech

Description:

Carbometrics is a specialist chemistry company .Our core competency is the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules. Our technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Carbometrics’ goal is to exploit our GBM technology to realise a highly robust and accurate glucose sensing platform that can be used to create a market-leading Continuous Glucose Monitoring (CGM) solution. The company was set up after the founders sold their first company Ziylo to Novo Nordisk, which is using the same platform to develop smart insulins.

Total Funding Amount:

2.1M EUR

Headquarters Location:

Bristol, Bristol, City of, United Kingdom

Founded Date:

2018-01-01

Contact Email:

info(AT)carbometrics.com

Founders:

Andy Chapman, Harry Destecroix, Keith MacDonald

Number of Employees:

11-50

Last Funding Date:

2023-05-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai